I don't usually trade biotech, however, AMGEN is looking like a buy to me. Showing rejection from the 200ma with a bullish engulfing bar.
RSI was previously oversold at the 200ma along with the Stoch.
Strong fundamentals. One downgrade from Argus but most ratings still targeting 188-198.
Entry: 175
Stop - 167
TP1 - 188
TP2 - 200
RSI was previously oversold at the 200ma along with the Stoch.
Strong fundamentals. One downgrade from Argus but most ratings still targeting 188-198.
Entry: 175
Stop - 167
TP1 - 188
TP2 - 200
取消訂單:
Buy order not triggered as price failed to break higher. Price now below 200ma, trade invalid.